Semi-Annual Statement Of Cash Flows
Japan Animal Referral Medical Center Co.,Ltd. - Filing #7260598
| Concept |
2023-04-01 to 2024-03-31 |
As at 2024-03-31 |
2023-04-01 to 2024-03-31 |
As at 2023-03-31 |
2022-04-01 to 2023-03-31 |
2022-04-01 to 2023-03-31 |
As at 2022-03-31 |
|---|---|---|---|---|---|---|---|
| Semi-annual statement of cash flows | |||||||
| Statement of cash flows | |||||||
| Cash flows from operating activities | |||||||
| Profit (loss) before income taxes |
491,305,000
JPY
|
— |
285,446,000
JPY
|
— |
359,303,000
JPY
|
533,932,000
JPY
|
— |
| Depreciation |
444,101,000
JPY
|
— | — | — | — |
391,472,000
JPY
|
— |
| Increase (decrease) in allowance for doubtful accounts |
-1,871,000
JPY
|
— | — | — | — |
1,825,000
JPY
|
— |
| Interest expenses |
18,825,000
JPY
|
— | — | — | — |
17,592,000
JPY
|
— |
| Increase (decrease) in provision for bonuses |
31,061,000
JPY
|
— | — | — | — |
8,051,000
JPY
|
— |
| Decrease (increase) in trade receivables |
-33,826,000
JPY
|
— | — | — | — |
-34,376,000
JPY
|
— |
| Decrease (increase) in inventories |
15,494,000
JPY
|
— | — | — | — |
-40,862,000
JPY
|
— |
| Increase (decrease) in trade payables |
-2,457,000
JPY
|
— | — | — | — |
17,673,000
JPY
|
— |
| Other, net |
58,740,000
JPY
|
— | — | — | — |
26,950,000
JPY
|
— |
| Subtotal |
1,160,102,000
JPY
|
— | — | — | — |
983,022,000
JPY
|
— |
| Interest and dividends received |
56,000
JPY
|
— | — | — | — |
21,000
JPY
|
— |
| Interest paid |
-18,885,000
JPY
|
— | — | — | — |
-17,436,000
JPY
|
— |
| Income taxes paid |
-241,490,000
JPY
|
— | — | — | — |
-161,720,000
JPY
|
— |
| Net cash provided by (used in) operating activities |
899,782,000
JPY
|
— | — | — | — |
810,922,000
JPY
|
— |
| Cash flows from investing activities | |||||||
| Purchase of property, plant and equipment |
-1,041,040,000
JPY
|
— | — | — | — |
-728,305,000
JPY
|
— |
| Proceeds from sale of property, plant and equipment |
1,625,000
JPY
|
— | — | — | — |
218,000
JPY
|
— |
| Other, net |
117,000
JPY
|
— | — | — | — |
-10,867,000
JPY
|
— |
| Net cash provided by (used in) investing activities |
-985,860,000
JPY
|
— | — | — | — |
-784,065,000
JPY
|
— |
| Cash flows from financing activities | |||||||
| Proceeds from long-term borrowings |
489,900,000
JPY
|
— | — | — | — |
625,300,000
JPY
|
— |
| Repayments of long-term borrowings |
-609,037,000
JPY
|
— | — | — | — |
-571,576,000
JPY
|
— |
| Proceeds from issuance of shares |
11,250,000
JPY
|
— | — | — | — |
771,549,000
JPY
|
— |
| Purchase of treasury shares |
-328,616,000
JPY
|
— | — | — | — |
JPY
|
— |
| Net cash provided by (used in) financing activities |
-392,322,000
JPY
|
— | — | — | — |
820,586,000
JPY
|
— |
| Other, net |
-759,000
JPY
|
— | — | — | — |
-2,777,000
JPY
|
— |
| Effect of exchange rate change on cash and cash equivalents |
JPY
|
— | — | — | — |
JPY
|
— |
| Net increase (decrease) in cash and cash equivalents |
-478,400,000
JPY
|
— | — | — | — |
847,443,000
JPY
|
— |
| Cash and cash equivalents | — |
1,337,639,000
JPY
|
— |
1,816,039,000
JPY
|
— | — |
968,595,000
JPY
|